Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | KYMR | SYRE | ||
| Company | Protagonist Therapeutics Inc | Kymera Therapeutics Inc | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 109.85 | 82.53 | 81.09 | ||
| High | 111.78 | 88.58 | 84.43 | ||
| Low | 109.60 | 82.53 | 80.72 | ||
| Latest | 109.78 | 86.21 | 80.79 | ||
| Change | -0.01 | +3.25 | +0.02 | ||
| % Change | -0.01% | +3.91% | +0.02% | ||
| Volume | 448,800 | 625,200 | 958,700 | ||
| 20-Day Average Volume | 573,955 | 579,110 | 1,062,855 | ||
| Previous Close | 109.79 | 82.96 | 80.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 100.93 | 78.77 | 73.71 | ||
| 20-Day Raw Stochastic | 89.51% | 87.57% | 81.58% | ||
| 20-Day Relative Strength | 58.93 | 57.52 | 61.27 | ||
| Weighted Alpha | +77.50 | +59.96 | +324.37 | ||
| Today's Opinion | 88% Buy | 64% Buy | 100% Buy | ||
| Previous Opinion | 88% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.73% since 06/05/26 | +16.29% since 06/05/26 | +9.69% since 06/05/26 | ||
| Low | 96.70 on 06/08/26 | 73.05 on 06/09/26 | 70.89 on 06/09/26 | ||
| High | 111.78 on 06/12/26 | 88.58 on 06/12/26 | 84.43 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | +9.83% since 05/12/26 | +3.18% since 05/12/26 | +7.66% since 05/12/26 | ||
| Low | 92.75 on 06/02/26 | 69.48 on 06/03/26 | 64.67 on 05/19/26 | ||
| High | 111.78 on 06/12/26 | 88.58 on 06/12/26 | 84.43 on 06/12/26 | ||
| 3-Month | |||||
| %Chg | +15.05% since 03/12/26 | +11.23% since 03/12/26 | +99.93% since 03/12/26 | ||
| Low | 90.58 on 03/18/26 | 69.48 on 06/03/26 | 39.00 on 03/13/26 | ||
| High | 111.78 on 06/12/26 | 90.14 on 04/15/26 | 84.43 on 06/12/26 | ||
| 6-Month | |||||
| %Chg | +15.13% since 12/12/25 | -3.87% since 12/12/25 | +140.30% since 12/12/25 | ||
| Low | 77.00 on 02/23/26 | 66.21 on 01/20/26 | 28.00 on 01/05/26 | ||
| High | 111.78 on 06/12/26 | 95.90 on 02/26/26 | 84.43 on 06/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,060,061 | 7,091,051 | 7,015,885 | ||
| Shares Outstanding, K | 64,311 | 82,258 | 86,841 | ||
| Annual Sales | 46,020,000 | 39,210,000 | 0 | ||
| Annual Net Income | -130,150,000 | -311,350,000 | -155,200,000 | ||
| Last Quarter Sales | 56,370,000 | 34,370,000 | 0 | ||
| Last Quarter Net Income | 3,780,000 | -69,230,000 | -69,010,000 | ||
| 60-Month Beta | 1.85 | 2.02 | 3.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 05/05/26 | -0.71 on 04/30/26 | -0.74 on 05/05/26 | ||
| Earnings Date | 08/05/26 | 08/10/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||